Evaluation of isuprelfranol in the treatment of the asthmatic attack.
D001249:Asthma / Q000628:therapy*; D002317:Cardiovascular Agents; D006801:Humans; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D009638:Norepinephrine / Q000031:analogs & derivatives
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central; D009638:Norepinephrine
ARTERENOL/derivatives; ASTHMA/therapy; MUSCLE RELAXANTS/therapeutic use